{"id":"502f710d-9b68-4ce3-89c0-3fd753ce253b","name":"Smith+Nephew","slug":"smith-nephew","description":"Smith+Nephew is a British multinational medical technology company headquartered in Watford, England, and a FTSE 100 constituent (LSE: SN, NYSE: SNN). Founded in 1856 by Thomas James Smith in Kingston upon Hull, the company develops the CORI handheld robotic surgical platform for orthopaedic procedures including partial and total knee arthroplasty and shoulder arthroplasty. Smith+Nephew reported $6.16B revenue in 2025 and employs approximately 18,000 people across 100+ countries.","status":"public (LSE: SN; NYSE: SNN)","founded":1856,"hq":"Watford, England, UK","fundingTotal":null,"type":"both","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.smith-nephew.com/en/news/2015/10/29/20151029-acquisition-of-blue-belt-technologies","title":"Smith+Nephew acquires Blue Belt Technologies for $275M (the NAVIO handheld system; Oct 29 2015)","sourceName":"Smith+Nephew"},{"url":"https://www.smith-nephew.com/en/news/2020/07/14/20200714-sn-launches-real-intelligence-and-cori-surgical-system","title":"Smith+Nephew launches Real Intelligence and the CORI Surgical System (NAVIO successor; Jul 14 2020)","sourceName":"Smith+Nephew"},{"url":"https://www.smith-nephew.com/en/news/2022/01/26/20220126-expands-next-generation-handheld-robotic-assisted-cori-surgical-system-into-total-hip","title":"Smith+Nephew expands CORI into total hip with RI.HIP NAVIGATION (Jan 26 2022; NAVIGATION-only, not robotic burring)","sourceName":"Smith+Nephew"}],"keyFacts":[{"label":"Product","value":"CORI Surgical System (handheld, imageless robotic knee surgery); NAVIO successor."},{"label":"Boundary","value":"AI-augmented surgeon-controlled handheld assistance, NOT autonomous."},{"label":"Stock listings","value":"LSE: SN; NYSE: SNN"},{"label":"Acquisition","value":"Acquired Blue Belt Technologies (NAVIO) in 2015 for $275M"},{"label":"CEO","value":"Deepak Nath (appointed April 2022)"},{"label":"Chairman","value":"Rupert Soames"},{"label":"Revenue","value":"US$6.164B (2025)"},{"label":"Operating income","value":"US$794M (2025)"},{"label":"Employees","value":"18,000 (2025)"},{"label":"Listed","value":"LSE: SN, NYSE: SNN"},{"label":"Founder","value":"Thomas James Smith (1856)"}],"aliases":["Smith & Nephew","Smith+Nephew plc","Blue Belt Technologies"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"createdAt":"2026-06-04T04:09:48.236Z","updatedAt":"2026-07-07T19:03:51.122Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/smith-nephew","url":"https://registry.deploy.report/companies/smith-nephew","name":"Smith+Nephew","alternateName":["Smith & Nephew","Smith+Nephew plc","Blue Belt Technologies"],"description":"Smith+Nephew is a British multinational medical technology company headquartered in Watford, England, and a FTSE 100 constituent (LSE: SN, NYSE: SNN). Founded in 1856 by Thomas James Smith in Kingston upon Hull, the company develops the CORI handheld robotic surgical platform for orthopaedic procedures including partial and total knee arthroplasty and shoulder arthroplasty. Smith+Nephew reported $6.16B revenue in 2025 and employs approximately 18,000 people across 100+ countries.","identifier":"502f710d-9b68-4ce3-89c0-3fd753ce253b","foundingDate":"1856","address":"Watford, England, UK","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":3,"primary_source_types":[]}}}